Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Eccles

Showing results (181-190 of 240) with videos related to

Pageof 24
Sort By:
Epilepsy Research|March 15, 2021
The MinION as a cost-effective technology for diagnostic screening of the SCN1A gene in epilepsy patientsThi Tuyet Dieu Ngo, Rodney A Lea, Neven Maksemous, et al.
The Journal of Experimental Medicine|December 4, 2016
Th2 responses are primed by skin dendritic cells with distinct transcriptional profilesLisa M Connor, Shiau-Choot Tang, Emmanuelle Cognard, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2010
Design and synthesis of novel pyrimidine hydroxamic acid inhibitors of histone deacetylasesAlastair D G Donald, Vanessa L Clark, Sanjay Patel, et al.
Frontiers in Oncology|August 8, 2018
Evaluating Imaging Biomarkers of Acquired Resistance to Targeted EGFR Therapy in Xenograft Models of Human Head and Neck Squamous Cell CarcinomaLauren C J Baker, Arti Sikka, Jonathan M Price, et al.
British Journal of Cancer|November 1, 2018
Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinomaNada M S Al-Saffar, Helen Troy, Anne-Christine Wong Te Fong, et al.
Plos Genetics|October 17, 2015
A Phenomic Scan of the Norfolk Island Genetic Isolate Identifies a Major Pleiotropic Effect Locus Associated with Metabolic and Renal Disorder MarkersMiles C Benton, Rodney A Lea, Donia Macartney-Coxson, et al.
Clinical Medicine (London, England)|January 22, 2021
Beyond bones: The relevance of variants of connective tissue (hypermobility) to fibromyalgia, ME/CFS and controversies surrounding diagnostic classification: an observational studyJessica A Eccles, Beth Thompson, Kristy Themelis, et al.
Molecular Cancer Therapeutics|January 8, 2010
The preclinical pharmacology and therapeutic activity of the novel CHK1 inhibitor SAR-020106Michael I Walton, Paul D Eve, Angela Hayes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivoJane Renshaw, Kathryn R Taylor, Ryan Bishop, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2012
Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibitionAleksandra Bielen, Gary Box, Lara Perryman, et al.
Pageof 24

Showing results (181-190 of 240) with videos related to

Sort By:
Pageof 24
Epilepsy Research|March 15, 2021
The MinION as a cost-effective technology for diagnostic screening of the SCN1A gene in epilepsy patientsThi Tuyet Dieu Ngo, Rodney A Lea, Neven Maksemous, et al.
The Journal of Experimental Medicine|December 4, 2016
Th2 responses are primed by skin dendritic cells with distinct transcriptional profilesLisa M Connor, Shiau-Choot Tang, Emmanuelle Cognard, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2010
Design and synthesis of novel pyrimidine hydroxamic acid inhibitors of histone deacetylasesAlastair D G Donald, Vanessa L Clark, Sanjay Patel, et al.
Frontiers in Oncology|August 8, 2018
Evaluating Imaging Biomarkers of Acquired Resistance to Targeted EGFR Therapy in Xenograft Models of Human Head and Neck Squamous Cell CarcinomaLauren C J Baker, Arti Sikka, Jonathan M Price, et al.
British Journal of Cancer|November 1, 2018
Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinomaNada M S Al-Saffar, Helen Troy, Anne-Christine Wong Te Fong, et al.
Plos Genetics|October 17, 2015
A Phenomic Scan of the Norfolk Island Genetic Isolate Identifies a Major Pleiotropic Effect Locus Associated with Metabolic and Renal Disorder MarkersMiles C Benton, Rodney A Lea, Donia Macartney-Coxson, et al.
Clinical Medicine (London, England)|January 22, 2021
Beyond bones: The relevance of variants of connective tissue (hypermobility) to fibromyalgia, ME/CFS and controversies surrounding diagnostic classification: an observational studyJessica A Eccles, Beth Thompson, Kristy Themelis, et al.
Molecular Cancer Therapeutics|January 8, 2010
The preclinical pharmacology and therapeutic activity of the novel CHK1 inhibitor SAR-020106Michael I Walton, Paul D Eve, Angela Hayes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivoJane Renshaw, Kathryn R Taylor, Ryan Bishop, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2012
Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibitionAleksandra Bielen, Gary Box, Lara Perryman, et al.
Pageof 24